Read up on Leronlimab & Lenzilumab. Both monoclonal antibodies , both available for emergency use through your Dr I believe.
Leronlimabs safety profile is excellent and
more trial results are due within the next week or so. Dr Bruce Patterson ( Ceo of incelldx, a bio tech diagnostics company) and former medical director of diagnostic virology at Stanford talks about how effective the drug was at stopping the cytokine storm
(over reaction of the bodys inmune system)
that attacks the bodies organs and can lead to death. In a Ted talk he says the drug stopped the cytokine storm, reduced the viral load to zero and improved T cell response.
This drug is flying under the radar as its owned by a small cap bio tech company
however, that may change very quickly depending on upcoming trial results.
Drug #2 Lenzilumab is in phase 3 trials and is also currently in trial with Remdesivir (Gilead).
A small study recently completed in the Mayo cliinic "showed rapid clinical improvement " median time to recovery and discharge for the group was five days..
Both of these drugs work to stop the cytokine storm. Some people seem to get into real trouble when the disease turns from a virologic disease to a severe immunologic disease. These meds aim to stop that.
On a side note, someone ( big pharma) has connections. A ton of money has been thrown at Gilead (Remdesivir).
The trial results for the drug Remdesivir have been thoroughly underwhelming. Apparently it shortens hospital stays by a few days however, I dont see any clinical data to back this up. Its an anti viral but it didn't show any reduction in viral load. It also showed no reduction in mortality.The media seems to be mia as usual.
Good luck